Literature DB >> 17853904

A novel cytosolic class I antigen-processing pathway for endoplasmic-reticulum-targeted proteins.

Eva Schlosser1, Carolina Otero, Christine Wuensch, Benedikt Kessler, Mariola Edelmann, René Brunisholz, Ingo Drexler, Daniel F Legler, Marcus Groettrup.   

Abstract

Proteins bearing an endoplasmic reticulum (ER) leader are inserted into the ER followed by cleavage of the signal peptide. Major histocompatibility complex class I-restricted T-cell epitopes can be generated from these proteins by the proteasome after retrotranslocation into the cytosol. Here, we show that an HLA-A(*)0201-restricted epitope from prostate stem cell antigen contains the cleavage site of the ER signal peptidase. The resulting cleavage products fail to bind to HLA-A(*)0201 and are not recognized by T lymphocytes. As processing of prostate stem cell antigen by signal peptidase occurs immediately after co-translational insertion, the epitope must be processed from polypeptides that have never reached the ER. The processing of this epitope depends on the proteasome and the transporter associated with antigen processing and shows a novel pathway of class I processing that relies on the failure of ER-targeted proteins to reach their target compartment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17853904      PMCID: PMC2002554          DOI: 10.1038/sj.embor.7401065

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  13 in total

Review 1.  Signal sequences: more than just greasy peptides.

Authors:  B Martoglio; B Dobberstein
Journal:  Trends Cell Biol       Date:  1998-10       Impact factor: 20.808

2.  Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.

Authors:  H Schägger; G von Jagow
Journal:  Anal Biochem       Date:  1987-11-01       Impact factor: 3.365

3.  Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer.

Authors:  J Dannull; P A Diener; L Prikler; G Fürstenberger; T Cerny; U Schmid; D K Ackermann; M Groettrup
Journal:  Cancer Res       Date:  2000-10-01       Impact factor: 12.701

4.  An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins.

Authors:  J C Skipper; R C Hendrickson; P H Gulden; V Brichard; A Van Pel; Y Chen; J Shabanowitz; T Wolfel; C L Slingluff; T Boon; D F Hunt; V H Engelhard
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

5.  Introduction of a glycosylation site into a secreted protein provides evidence for an alternative antigen processing pathway: transport of precursors of major histocompatibility complex class I-restricted peptides from the endoplasmic reticulum to the cytosol.

Authors:  I Bacik; H L Snyder; L C Antón; G Russ; W Chen; J R Bennink; L Urge; L Otvos; B Dudkowska; L Eisenlohr; J W Yewdell
Journal:  J Exp Med       Date:  1997-08-18       Impact factor: 14.307

6.  Processing of HIV-1 envelope glycoprotein for class I-restricted recognition: dependence on TAP1/2 and mechanisms for cytosolic localization.

Authors:  R L Ferris; C Hall; N V Sipsas; J T Safrit; A Trocha; R A Koup; R P Johnson; R F Siliciano
Journal:  J Immunol       Date:  1999-02-01       Impact factor: 5.422

7.  An epitope-selective, transporter associated with antigen presentation (TAP)-1/2-independent pathway and a more general TAP-1/2-dependent antigen-processing pathway allow recognition of the HIV-1 envelope glycoprotein by CD8+ CTL.

Authors:  S A Hammond; R P Johnson; S A Kalams; B D Walker; M Takiguchi; J T Safrit; R A Koup; R F Siliciano
Journal:  J Immunol       Date:  1995-06-01       Impact factor: 5.422

8.  Hepatitis C virus envelope glycoprotein E1 originates in the endoplasmic reticulum and requires cytoplasmic processing for presentation by class I MHC molecules.

Authors:  M Selby; A Erickson; C Dong; S Cooper; P Parham; M Houghton; C M Walker
Journal:  J Immunol       Date:  1999-01-15       Impact factor: 5.422

9.  A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells.

Authors:  Anne L Ackerman; Alessandra Giodini; Peter Cresswell
Journal:  Immunity       Date:  2006-10-05       Impact factor: 43.474

10.  The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol.

Authors:  C A Mosse; L Meadows; C J Luckey; D J Kittlesen; E L Huczko; C L Slingluff; J Shabanowitz; D F Hunt; V H Engelhard
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

View more
  8 in total

Review 1.  DRiPs solidify: progress in understanding endogenous MHC class I antigen processing.

Authors:  Jonathan W Yewdell
Journal:  Trends Immunol       Date:  2011-09-29       Impact factor: 16.687

2.  Hydrophobicity as a driver of MHC class I antigen processing.

Authors:  Lan Huang; Matthew C Kuhls; Laurence C Eisenlohr
Journal:  EMBO J       Date:  2011-03-04       Impact factor: 11.598

3.  UBQLN4 recognizes mislocalized transmembrane domain proteins and targets these to proteasomal degradation.

Authors:  Rigel Suzuki; Hiroyuki Kawahara
Journal:  EMBO Rep       Date:  2016-04-22       Impact factor: 8.807

Review 4.  Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands.

Authors:  Brian P Dolan; Jack R Bennink; Jonathan W Yewdell
Journal:  Cell Mol Life Sci       Date:  2011-03-17       Impact factor: 9.261

5.  Defective ribosomal products are the major source of antigenic peptides endogenously generated from influenza A virus neuraminidase.

Authors:  Brian P Dolan; Lily Li; Kazuyo Takeda; Jack R Bennink; Jonathan W Yewdell
Journal:  J Immunol       Date:  2009-12-28       Impact factor: 5.422

6.  Just one position-independent lysine residue can direct MelanA into proteasomal degradation following N-terminal fusion of ubiquitin.

Authors:  Christian Setz; Melanie Friedrich; Sabine Hahn; Jan Dörrie; Niels Schaft; Gerold Schuler; Ulrich Schubert
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

7.  Gene Expression Driven by a Strong Viral Promoter in MVA Increases Vaccination Efficiency by Enhancing Antibody Responses and Unmasking CD8⁺ T Cell Epitopes.

Authors:  Pablo D Becker; Miriam Nörder; Sebastian Weissmann; Ronny Ljapoci; Volker Erfle; Ingo Drexler; Carlos A Guzmán
Journal:  Vaccines (Basel)       Date:  2014-07-22

8.  Elimination of a signal sequence-uncleaved form of defective HLA protein through BAG6.

Authors:  Koki Yamamoto; Mizuki Hayashishita; Setsuya Minami; Kanji Suzuki; Takumi Hagiwara; Aya Noguchi; Hiroyuki Kawahara
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.